Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is a global biopharmaceutical company headquartered in Dublin, Ireland, dedicated to innovating and transforming the lives of patients and their families. The company focuses on developing life-changing medicines for individuals with serious diseases, particularly in the fields of neuroscience and oncology, where therapeutic options may be limited. With a diverse portfolio that includes both marketed medicines and novel product candidates, Jazz Pharmaceuticals actively explores new treatment options through innovative compounds, small molecules, biologics, cannabinoid science, and advanced delivery technologies. The company operates globally, serving patients in nearly 75 countries and is committed to ethical pharmaceutical marketing and compliance with regulatory standards.